0
Skip to Content
Melafrica
Home
Projects
Research
Education
Sustainability
Our Vision
Our Team
Donate
Melafrica
Home
Projects
Research
Education
Sustainability
Our Vision
Our Team
Donate
Home
Folder: Projects
Back
Research
Education
Sustainability
Our Vision
Our Team
Donate
  • Haregewein Assefa , Ph.D.

    Haregewein Assefa , Ph.D.

    Chief Executive Officer

    Dr. Assefa is an accomplished Medicinal Chemistry with decades of experience in industry and academia. Dr. Assefa has strong passion to use her skills in making high quality pharmaceuticals available for people living in Africa and globally.

  • Gojeb Frehywot

    Chief Scientific Office

    Dr. Frehywot has broad scientific, technical, and legal expertise with passion to use his expertise to make broad availability of high quality medicines globally, especially in places where there is severe shortage of such medicines.

  • Yohannes Teffera, Ph.D.

    Member

    Dr Teffera has a broad experience in Drug Metabolism and Bioanalysis

  • Abebaw Fekadu, MD, PhD, MRCPsych

    Abebaw Fekadu, MD, PhD, MRCPsych

    Member

    Dr. Fekadu is professor of psychiatry at Addis Ababa University and leads CDT-Africa, an Africa Center of Excellence for research and education focusing on medical discovery and development. goes here

  • Eyasu Makonnen Eshetu, Ph.D.

    Member

    Professor of Pharmacology at Addis Ababa University and Member of the center for Innovative Drug Development &Therapeutic Trials for Africa (CDT Africa), College of Heath Sciences, Addis Ababa University.

  •  Shumet Hailu

    Shumet Hailu, Ph.D.

    Member

    Shumet joined Melafrica in 2023 as a Co-founder and member of the Executive Leadership Team. Shumet is a drug development leader in Chemistry, Manufacturing and Controls (CMC). He brings many years of industry experience in both big and small Pharma CMC activities at all phases of drug development from preclinical through clinical to commercial. In his career, Shumet has been highly involved in and led CMC teams responsible for successful approval and commercial launch of several drug products to market. Shumet earned his Ph.D. in Pharmaceutical Sciences from University of Connecticut, and M.Sc. in Pharmaceutics and B.Sc. in Pharmacy from Addis Ababa University.

  • Bahru Habtemariam, Pharm.D.

    Member

    Dr. Habtemariam is a Clinical Pharmacologist with more than 15 years regulatory (US FDA) and industry experience.

Melafrica

Cambridge, MA. USA.


Phone: 617-800-5331

e-mail: gfrehywot@gmail.com

Projects

Materials  for Learning
Education for Teachers
Support for Communities

About

Our Vision
Donate